Instil Bio (TIL) Shares Outstanding (Entity) (2020 - 2026)
Instil Bio (TIL) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 575.47 Mn |
| 10 | Instil Bio | 51.14 Mn | 51.14 Mn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.78 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 6.78 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.75 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Dec 31, 2024 | 6.53 Mn |
| Sep 30, 2024 | 6.53 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.50 Mn |
| Dec 31, 2023 | 6.50 Mn |
| Sep 30, 2023 | 6.50 Mn |
| Jun 30, 2023 | 6.50 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.50 Mn |
| Sep 30, 2022 | 6.49 Mn |
| Jun 30, 2022 | 6.48 Mn |
| Mar 31, 2022 | 6.46 Mn |
| Dec 31, 2021 | 5.30 Mn |
| Sep 30, 2021 | 6.44 Mn |